RCMI Coordinating Center (RCMI CC) Header Logo

William Haning, MD

TitleAssociate Chair of Psychiatry/Program Director, General Psychiatry Residency
Faculty RankProfessor
InstitutionUniversity of Hawaii
DepartmentPsychiatry
AddressThe Queen's Medical Center
1356 Lusitana St.
QUT 403
Honolulu HI 96813
Phone8085867436
Fax8085862940
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    William F. Haning, III, M.D., FASAM, DFAPA
    (“Bill”)

    Dr. William Haning is a tenured Professor of Psychiatry at the John A. Burns School of Medicine, University of Hawai’i, who serves as the Director, Psychiatry Residency Training Programs and as the Associate Chair for Education of the Department of Psychiatry. He a chair of the medical student neuroscience curriculum for that school. He also co-directs training programs in Addiction Medicine and Addiction Psychiatry, and is Principal Investigator for the Pacific Addiction Research Center (PARC®). Nationally, he is a Director of the American Society of Addiction Medicine; and the designated Chair of the Examination Committee for Addiction Psychiatry, American Board of Psychiatry and Neurology. He holds an A.B. (Philosophy) from Princeton University and an M.D. from the University of Hawai`i at Manoa. He is a Fellow of the American Society of Addiction Medicine and a Distinguished Fellow of the American Psychiatric Association.

    Dr. Haning is certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine; has received teaching awards inclusive of the APA’s Nancy C.A. Roeske Certificate, the John M. Hardman mentorship award from the John A. Burns School of Medicine of the University of Hawai`i, and the University of Hawai`i Regents Medal; and has chaired a number of community service boards including the Life Foundation and the Hawai’i Program for Healthcare Professionals. The past Force Surgeon for U.S. Marine Forces Pacific, and for Marine Forces Central Command in Operation Iraqi Freedom, he served also as the Division Psychiatrist, 4th Marine Division. A Captain in the Navy Reserve, he transferred to the Retired Reserve in 2009 and continues to serve as the Professional Services Liaison Officer for Hawai`i; his awards include the Legion of Merit.

    He spends a lot of time trying to defeat age through exercise, which seems only to wear him out; and an equal amount of time trying to understand humanity by reading history, which only raises more questions. He lives in Manoa Valley in Honolulu where he is the undeserving spouse of the remarkable Dr. Libby Char, Assistant Clinical Professor of Surgery in Emergency Medicine.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Haning W. Letter of Appreciation to Richard Saitz, MD, MPH, DFASAM, Editor-in-Chief. J Addict Med. 2022 Jan-Feb 01; 16(1):e1. PMID: 35020697.
      Citations:    Fields:    
    2. Buffenstein I, Kiyokawa M, Haning W. Severe Hypothyroidism in a Hypomanic Patient With Sepsis. Prim Care Companion CNS Disord. 2021 Nov 24; 23(6). PMID: 34818469.
      Citations:    Fields:    Translation:Humans
    3. Cape MC, Kiyokawa M, Haning WF. Astronomical Use of Nitrous Oxide Associated With Stress From the COVID-19 Pandemic and Lockdown. Prim Care Companion CNS Disord. 2021 09 23; 23(5). PMID: 34559481.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    4. Juul D, Haning WF, Ronis RJ, Faulkner LR. The Development and Current Status of Subspecialty Training and Certification in Addiction Psychiatry. Acad Psychiatry. 2022 Jun; 46(3):311-316. PMID: 34331273.
      Citations:    Fields:    Translation:Humans
    5. Haning W. Commentary on "Civil Commitment for SUDs: A National Survey of Addiction Medicine Physicians". J Addict Med. 2021 Jul-Aug 01; 15(4):283-284. PMID: 33989261.
      Citations: 1     Fields:    Translation:Humans
    6. Kiyokawa M, Haning WF. Hydromorphone-Induced Tactile Hallucinations: Rare Opioid Side Effect. Cureus. 2021 Feb 28; 13(2):e13622. PMID: 33816021.
      Citations:    
    7. Park TM, Haning WF. Stimulant Use Disorders. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3):461-71. PMID: 27338967.
      Citations: 4     Fields:    Translation:Humans
    8. Fong SF, Sakai DH, Kasuya RT, Kramer K, Wong VS, Haning W, Asano I, Uyehara-Lock JH, Thompson K, Omori JS, Hirose-Wong SM, Horio DT. Medical School Hotline: Liaison Committee on Medical Education Accreditation, Part IV: Pre-clerkship Education. Hawaii J Med Public Health. 2016 Feb; 75(2):48-51. PMID: 26918209.
      Citations: 6     Fields:    Translation:Humans
    9. Smith LM, Diaz S, LaGasse LL, Wouldes T, Derauf C, Newman E, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM. Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study. Neurotoxicol Teratol. 2015 Sep-Oct; 51:35-44. PMID: 26212684.
      Citations: 20     Fields:    Translation:HumansAnimals
    10. Anderson AL, Li SH, Markova D, Holmes TH, Chiang N, Kahn R, Campbell J, Dickerson DL, Galloway GP, Haning W, Roache JD, Stock C, Elkashef AM. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 2015 May 01; 150:170-4. PMID: 25818061.
      Citations: 25     Fields:    Translation:Humans
    11. Li MD, Wang J, Niu T, Ma JZ, Seneviratne C, Ait-Daoud N, Saadvandi J, Morris R, Weiss D, Campbell J, Haning W, Mawhinney DJ, Weis D, McCann M, Stock C, Kahn R, Iturriaga E, Yu E, Elkashef A, Johnson BA. Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction. BMC Med Genomics. 2014 Dec 12; 7:65. PMID: 25495887.
      Citations: 7     Fields:    Translation:HumansCells
    12. Kiblawi ZN, Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, DellaGrotta S, Dansereau LM, Neal C, Lester B. Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study. Subst Abus. 2014; 35(1):68-73. PMID: 24588296.
      Citations: 14     Fields:    Translation:Humans
    13. Kirlic N, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Abar B, Neal CR, Lester BM. Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine. J Stud Alcohol Drugs. 2013 May; 74(3):447-51. PMID: 23490574.
      Citations: 9     Fields:    Translation:Humans
    14. Liles BD, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Neal C, Lester BM. Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users. Child Psychiatry Hum Dev. 2012 Dec; 43(6):943-57. PMID: 22552952.
      Citations: 13     Fields:    Translation:Humans
    15. Ma JZ, Johnson BA, Yu E, Weiss D, McSherry F, Saadvandi J, Iturriaga E, Ait-Daoud N, Rawson RA, Hrymoc M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D, McCann M, Pham T, Stock C, Dickinson R, Elkashef A, Li MD. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):45-51. PMID: 23142494.
      Citations: 14     Fields:    Translation:Humans
    16. Smith LM, Paz MS, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM. Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study. Depress Anxiety. 2012 Jun; 29(6):515-22. PMID: 22555777.
      Citations: 10     Fields:    Translation:Humans
    17. Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, Smith LM, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Roberts MB, Neal C, Lester BM. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol. 2012 May; 29(5):391-400. PMID: 22399214.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    18. Elkashef A, Kahn R, Yu E, Iturriaga E, Li SH, Anderson A, Chiang N, Ait-Daoud N, Weiss D, McSherry F, Serpi T, Rawson R, Hrymoc M, Weis D, McCann M, Pham T, Stock C, Dickinson R, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Li MD, Johnson BA. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction. 2012 Jul; 107(7):1297-306. PMID: 22221594.
      Citations: 37     Fields:    Translation:Humans
    19. Wright TE, Schuetter R, Fombonne E, Stephenson J, Haning WF. Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J. 2012 Jan 19; 9:5. PMID: 22260315.
      Citations: 22     Fields:    
    20. Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):135-41. PMID: 21840138.
      Citations: 56     Fields:    Translation:Humans
    21. Zabaneh R, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau LM, Lin H, Neal C, Lester BM. The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol. 2012 Mar; 29(3):203-10. PMID: 21818727.
      Citations: 16     Fields:    Translation:Humans
    22. Derauf C, LaGasse L, Smith L, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau L, Lin H, Lester B. Infant temperament and high-risk environment relate to behavior problems and language in toddlers. J Dev Behav Pediatr. 2011 Feb-Mar; 32(2):125-35. PMID: 21200329.
      Citations: 20     Fields:    Translation:Humans
    23. Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, Arria A, Huestis M, Strauss A, Della Grotta S, Dansereau LM, Lin H, Lester BM. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol. 2011 Jan-Feb; 33(1):176-84. PMID: 21256431.
      Citations: 28     Fields:    Translation:Humans
    24. Nguyen D, Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr. 2010 Aug; 157(2):337-9. PMID: 20570284.
      Citations: 42     Fields:    Translation:HumansPHPublic Health
    25. Bell CK, Guerrero A, Matsu C, Takeshita J, Haning W, Schultz K. Curricular adaptations in inpatient child psychiatry for the 21st century: the Flexner model revisited. Acad Psychiatry. 2010 May-Jun; 34(3):195-202. PMID: 20431098.
      Citations:    Fields:    Translation:Humans
    26. Tice AD, Bannan M, Bauman K, Collis T, Hall A, Haning W, Hannemann S, Hare CB, Humphry J, Jao R, Leevy C, Lusk H, Ochoa E, Palafox N, Withers N, Akinaka K. Viral hepatitis in Hawai'i--differing perspectives. Hawaii Med J. 2010 Apr; 69(4 Suppl 1):3-20. PMID: 20533191.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    27. Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria A, Haning W, Della Grotta S, Strauss A, Lester BM, Huestis MA. New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. Clin Chem. 2010 May; 56(5):856-60. PMID: 20185623.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    28. Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit. 2009 Dec; 31(6):769-75. PMID: 19935364.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    29. Mooney LJ, Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Hunter J, Haning W, Colescott P, Ling W, Rawson R. Health conditions in methamphetamine-dependent adults 3 years after treatment. J Addict Med. 2009 Sep; 3(3):155-63. PMID: 21769012.
      Citations: 7     Fields:    
    30. Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Haning W, Grant P, Shah R, Arria A, Strauss A, Lester BM, Huestis MA. Novel biomarkers of prenatal methamphetamine exposure in human meconium. Ther Drug Monit. 2009 Feb; 31(1):70-5. PMID: 19125148.
      Citations: 5     Fields:    Translation:Humans
    31. Paz MS, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol. 2009 May-Jun; 31(3):177-82. PMID: 19059478.
      Citations: 19     Fields:    Translation:Humans
    32. Nakama H, Chang L, Cloak C, Jiang C, Alicata D, Haning W. Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict. 2008 Sep-Oct; 17(5):441-6. PMID: 18770088.
      Citations: 27     Fields:    Translation:Humans
    33. Jacobs JL, Kasuya R, Sakai D, Haning W, Izutsu S. Medical education in paradise: another facet of Hawaii. Med Teach. 2008 Jun; 30(5):490-5. PMID: 18576187.
      Citations: 2     Fields:    
    34. Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Fallone M, Liu J, Lester BM. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol. 2008 Jan-Feb; 30(1):20-8. PMID: 18031987.
      Citations: 76     Fields:    Translation:Humans
    35. Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology. 2008 Apr; 33(5):1162-70. PMID: 17581531.
      Citations: 101     Fields:    Translation:HumansCTClinical Trials
    36. Haning W, Goebert D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction. 2007 Apr; 102 Suppl 1:70-5. PMID: 17493055.
      Citations: 24     Fields:    Translation:Humans
    37. Elkashef A, Rawson RA, Smith E, Pearce V, Flammino F, Campbell J, Donovick R, Gorodetzky C, Haning W, Mawhinney J, McCann M, Weis D, Williams L, Ling W, Vocci F. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity. Addiction. 2007 Apr; 102 Suppl 1:107-13. PMID: 17493059.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    38. Derauf C, LaGasse LL, Smith LM, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse. 2007; 33(2):281-9. PMID: 17497551.
      Citations: 22     Fields:    Translation:Humans
    39. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006 Sep; 118(3):1149-56. PMID: 16951010.
      Citations: 88     Fields:    Translation:Humans
    40. Chang L, Haning W. Insights from recent positron emission tomographic studies of drug abuse and dependence. Curr Opin Psychiatry. 2006 May; 19(3):246-52. PMID: 16612209.
      Citations: 4     Fields:    Translation:Humans
    41. Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, Huestis M, Strauss A, Della Grotta S, Liu J, Lester B. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J. 2006 May; 10(3):293-302. PMID: 16395620.
      Citations: 67     Fields:    Translation:Humans
    42. Haning WF. Comments on planning and the 3 Tesla MRI. Hawaii Med J. 2005 Apr; 64(4):104-5. PMID: 15921248.
      Citations:    Fields:    Translation:Humans
    43. Baker FM, Haning WF. Substance abuse and dependence in a public hospital: Hawaii. Hawaii Med J. 2001 Feb; 60(2):35-8. PMID: 11258162.
      Citations:    Fields:    Translation:Humans
    44. Adams D, Ditzler T, Haning WF. Primary caffeine dependence: a case report. Hawaii Med J. 1993 Jul; 52(7):190-1, 194. PMID: 8365873.
      Citations: 1     Fields:    Translation:Humans
    Haning's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (173)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support